Maximilian Diehn

Stanford University

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

Compare more Cancer Research professors.

h-index89
i10-index198
Publications750
Citations57,533

Grants

10 total · 2 active

NIH #R01CA290715

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$600K–$700K
Period
2024-05-15 → 2029-04-30
PIs
2

NIH #P01CA257907

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

Active
Amount
$2M–$3M
Period
2022-09-21 → 2027-08-31
PIs
2

NIH #R01CA257655

Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma

Amount
$600K–$700K
Period
2021-03-04 → 2026-02-28
PIs
2

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

10 total · 2 active

NIH #R01CA290715

Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy

Active
Amount
$600K–$700K
Period
2024-05-15 → 2029-04-30
PIs
2

NIH #P01CA257907

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

Active
Amount
$2M–$3M
Period
2022-09-21 → 2027-08-31
PIs
2

NIH #R01CA257655

Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma

Amount
$600K–$700K
Period
2021-03-04 → 2026-02-28
PIs
2

NIH #R01CA244526

Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer

Amount
$600K–$700K
Period
2020-07-01 → 2025-06-30
PIs
3

NIH #R01CA254179

Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer

Amount
$600K–$700K
Period
2020-08-01 → 2025-04-30
PIs
2

NIH #R01CA233975

A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy

Amount
$500K–$600K
Period
2019-08-01 → 2024-07-31
PIs
2

NIH #R01CA233578

Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancer

Amount
$500K–$600K
Period
2019-02-01 → 2024-01-31
PIs
3

NIH #R01CA188298

Noninvasive monitoring of lung cancer patients treated with radiotherapy

Amount
$300K–$400K
Period
2015-06-01 → 2020-05-31
PIs
2

NIH #R44CA199142

Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens

Amount
$700K–$800K
Period
2015-08-17 → 2019-07-31
PIs
3

Awarded at CELL DATA SCIENCES, INC.

NIH #DP2CA186569

Developing a genomic approach for cancer screening

Amount
$2M–$3M
Period
2013-09-30 → 2018-06-30
PIs
1

Recent Public Signals

  1. New paper: A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC (Science Advances)2026-07-03
  2. New preprint: Knowledge Graph Modulated Deep Learning for Limited-Sample Clinical Data Analysis2026-05-22
  3. New NIH award: Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy2024-05-15

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-2032-0581

Professor Insights

Career Trajectory